Sproxil Appoints Dr. Gunther L. Faber, C. Hunter Boll & Nicholas Donofrio to Board of Directors

Sproxil, a U.S.-based company that provides world-class brand protection in emerging markets through software and services that work anywhere there are mobile phones, today announced the appointments of Dr. Gunther L. Faber, C. Hunter Boll and Nicholas Donofrio to its Board of Directors.

Each brings a background of extensive industry and consumer experiences that enrich the company's mission and complement Sproxil's efforts to provide a user-friendly solution that requires minimal education and training to use on the part of consumers.

“Having been involved in healthcare in the developing world for the past 30 years, one can't help but develop an anger against those individuals/syndicates who profit by producing counterfeit drugs at an industrial scale and marketing these efforts to the most vulnerable, the poor,” said Dr. Gunther L. Faber, CEO of The HealthStore Foundation. “It is organizations like Sproxil - prepared to tackle this practice head-on - who play a vital part in stemming the tide of counterfeit drugs. I am indeed pleased to be one of the group of Directors on the Board of a company committed to making safe drugs a given in the developing world.”

Sproxil 's Mobile Product Authentication™ (MPA) technology capitalizes on technologies that already exist and are readily accessible and easily understood by all levels of society - namely cellular phone SMS capabilities and scratch-off lottery-style labels. The company's services allow end consumers to verify with a simple free text message that they are not purchasing counterfeit medication. With Sproxil's technology, consumers start buying genuine drugs over spurious ones and pharmaceutical companies pay service fees to Sproxil for the increase in sales of genuine pharmaceutical products.

Dr. Gunther L. Faber, former Vice President, Sub-Saharan Africa, for GlaxoSmithKline, has more than 30 years of experience working within the pharmaceutical industry. He is CEO of The HealthStore Foundation®, the franchisor of the CFW franchise (Child and Family Wellness) in Sub-Saharan Africa. The HealthStore Foundation® has accumulated nearly a decade of experience developing and operating a healthcare franchise network in Kenya. Dr. Faber interacts at senior political and bureaucratic level with African governments, as well as those of the OECD countries. Dr. Faber is a member of the Africa Regional Advisory Board of London Business School.

C. Hunter Boll serves as Chief Operating Officer for Source Audio LLC, and is a director of Metrics Companies, Inc., TransWestern Publishing and Source Audio LLC. A former managing director of Thomas H. Lee Partners, one of the largest private equity firms in the world, Boll co-founded Source Audio LLC, a start-up venture focused on providing consumers with next generation accessories for the musical instrument market. A member of Acumen Fund's Board of Directors, Boll previously worked with the Boston Consulting Group and served as an Assistant Vice President, Energy and Mineral Division of Chemical Bank. Boll received a BA in Economics from Middlebury College and an MBA from the Stanford Graduate School of Business.

Nicholas M. Donofrio, a senior fellow at the Ewing Marion Kauffman Foundation, is a 44-year IBM veteran, now retired, who serves as an IBM fellow, the company's highest technical honor. Donofrio holds seven technology patents, is a member of numerous technical and science honor societies, and holds several board positions. Donofrio earned a Bachelor of Science degree in electrical engineering from Rensselaer Polytechnic Institute in 1967 and a Master of Science in the same discipline from Syracuse University in 1971. He holds numerous honorary doctorate degrees from universities in the United States, England, and Scotland.

“The addition of Dr. Faber, Mr. Donofrio and Mr. Hunter to our Board of Directors will strengthen our ability to connect consumers to manufacturers in an easy, affordable and scalable way that enables legitimate manufacturers and distributors to enhance patient safety and increase their sales by reducing the number of fake products purchased by patients and consumers in the developing world,” said Dr. Ashifi Gogo, CEO of Sproxil. “We look forward to parlaying their diverse experiences and backgrounds to provide even greater traction - and enhancements - to the technology behind our MPA solution.”
Companies in this article
More in Home